Insights from BCC Research

An Introduction to Biomarkers

Posted by BCC Research Staff Analysts on Sep 3, 2018 11:00:00 AM

Biomarkers_Image

Read More

Topics: Biotechnology, Life Sciences

What is Synthetic Biology?

Posted by John Bergin on Jul 13, 2018 10:00:00 AM

Synthetic_BiologyThe following is an excerpt from BCC Research Report “Synthetic Biology: Global Markets” by John Bergin.

Read More

Topics: Biotechnology, Life Sciences

This Pill Swallowing You? (Part Two)

Posted by Chris Spivey on Jun 11, 2018 8:46:00 AM

Pharmaceutical Drug

It is now normal to call biotech and small pharma the innovation engines for the pharmaceutical industry. IPO and ICOs abound, as dollars from venture capital truly flood the ecosystem. In 2018, biopharma investment is having a moment. Any big fluctuation, even a positive one, makes stakeholders nervous. Some of the investors might be tourists—Amazon, Google, Apple, IBM, JP Morgan, Berkshire Hathaway and a half dozen others are new entrants, whose long term goals remain unclear. Particularly disturbing are the health insurance and supply chain changes that make headlines, such as this one.

Read More

Topics: Pharmaceuticals, Life Sciences

This Pill Swallowing You?

Posted by Chris Spivey on Jun 4, 2018 12:04:00 PM

Pill

Urgency for an Antidote to Elephantitis

Read More

Topics: Pharmaceuticals, Life Sciences